Skip to content
Company Analysis

Citius Oncology, Inc. CTOR

A comprehensive view of key metrics, scores, and financial health for Citius Oncology, Inc.

Overview of Citius Oncology, Inc.

CTOR NCM
Healthcare Drug Manufacturers - Specialty & Generic Micro Cap
Citius Oncology, Inc. (CTOR), is a Micro Cap company, in the Drug Manufacturers - Specialty & Generic industry, last closed at $0.81, about 0.0% overvalued vs fair value, +38.1% 1Y return, ranked 723/1111 in sector.
$0.81
-10.77%
As of March 13, 2026
Previous close • Vol 90d: 91.9%
52-Week Range
Market Cap
$71.71M
Enterprise Value
$68.22M
Overall Score
Scores locked

Create a free account to see overall and pillar scores for Citius Oncology, Inc..

Top Beats
No strong beats yet

Quick Facts

HQ Cranford, NJ
Fiscal year Sep 30

Next Events

No upcoming events available.

Fair Value Snapshot

Insufficient data
Show more details
  • Revenue data missing or non-positive

Engine Room Money Flow™

Micro Cap

Pharmaceutical / Mature Biotech - Where revenue goes and how value is created

Flow Steps
Total Revenue
$0
R&D Expense
$6.4M
30.3%%
Operating Income (EBIT)
$-23.5M
-14.2%%
Operating Cash Flow
$-5.5M
-4446.6%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Pharmaceutical / Mature Biotech

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
0/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Citius Oncology, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
31
/100
Developing
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Weak
0
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 44% Coverage
Trade-Off Triangle Visualization A ternary plot showing CTOR's balance between Growth (39.1%), Profitability (30.1%), and Safety (30.8%). Growth 39% Safety 31% Profitability 30%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

- vs peers
-
Key Signals
EPS Growth YoY -8.8% 30p
Strengths

No notable strengths identified for this axis.

Risks

No significant risks identified for this axis.

Profitability

25th percentile vs peers
26
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

26th percentile vs peers
26
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Citius Oncology, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
-
- - -
- upside
-
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info